TrialHuman vaccines & immunotherapeutics2021
Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study.
Feng-Cai Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.